NPLATE subst sèche 125 mcg flac
7680690650018
CH-69065
B02BX04
06.99.0.
Reimbursement limitations:
NPLATE4
Nplate est indiqué chez les patients adultes présentant une thrombopénie immunologique primaire (PTI), réfractaire aux …
1 / 3
google
Details
- Product number
- 6906501
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- romiplostimum 125 µg, mannitolum, saccharum, histidinum, polysorbatum 20, acidum hydrochloridum dilutum pro vitro.
Articles (1)
Nplate 125 mcg, Pulver zur Herstellung einer Injektionslösung
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
125.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 259.70
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2024
Authorization holder
Amgen Switzerland AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 69065
- Drug name
- Nplate 125 mcg, Pulver zur Herstellung einer Injektionslösung
- Galenic form
- PULVL
- ATC Code
- B02BX04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 06/06/2023
- Authorization expiration date
- 05/06/2028
- IT number
- 06.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NPLATE subst sèche 125 mcg flac
- Description (DE)
- NPLATE Trockensub 125 mcg Durchstf
- Market launch
- 06/06/2023
- Narcotic (BTM)
- No